CGN Nuclear Technology Development Co Ltd
CGN Nuclear Technology Development Co Ltd is engaged in the production and sale of chemicals, primarily serving the commodity chemicals industry.
Business. CGN Nuclear Technology Development Co Ltd (000881.SZ) is a Chinese company primarily engaged in the commodity chemicals industry within the broader chemicals sector. The firm is listed on the Shenzhen Stock Exchange. Specific details regarding its operating segments and geographic presence are not available.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
CGN Nuclear Technology Development Co Ltd (000881.SZ) has undergone a significant reclassification in its business taxonomy, with its primary activity now identified as "Chemicals" and its economic sector designated as "Basic Materials." This shift represents a medium-severity change in the company's profile, moving from an undefined classification to a specific industrial categorization that aligns with the chemical and materials manufacturing space. Concurrently, the company's risk assessment framework has been updated with new baseline metrics. Dilution risk is now classified as "low," indicating a stable capital structure with minimal threat of share value erosion from new issuances. This assessment provides a clearer picture of shareholder equity protection, a key factor for long-term investors monitoring capital allocation strategies. In contrast, liquidity risk has been established at a "medium" level. This classification suggests that while the company maintains operational fluidity, there are moderate considerations regarding the ease of trading its shares or accessing immediate capital without significant price impact. This metric is crucial for understanding the stock's trading dynamics and potential volatility under market stress. These updates collectively refine the investment thesis for CGN Nuclear Technology Development, offering a more granular view of its sector positioning and risk profile. With no current analyst coverage or index membership data available, these newly defined risk and taxonomy parameters serve as foundational indicators for evaluating the company's standing within the Basic Materials sector.
Signals & dispatch
Composite-score breakdown
Synthesis
CGN Nuclear Technology Development Co Ltd (000881.SZ) is a Chinese company primarily engaged in the commodity chemicals industry within the broader chemicals sector. The firm is listed on the Shenzhen Stock Exchange. Specific details regarding its operating segments and geographic presence are not available.
The company's capital structure is characterized by a debt-to-equity ratio of 0.62, indicating a moderate reliance on debt financing. Despite a negative net income of -362.17 million CNY, the company maintains a current ratio of 1.91, suggesting reasonable short-term liquidity. However, the free cash flow is negative at -621.29 million CNY, and capital expenditures are substantial at -543.92 million CNY, indicating ongoing investment in operations.
Profitability metrics are weak, with a return on equity of -6.92% and a return on assets of -3.38%, both significantly below the typical performance of the Commodity Chemicals industry. The company's operating income is negative at -332.67 million CNY, and gross profit is only 752.21 million CNY, highlighting the challenges in maintaining profitability in a competitive industry.
The company's revenue is concentrated in a single business segment, as disclosed in its financials, with no geographic diversification provided in the available data. This lack of diversification may expose the company to higher operational and market risks, particularly in the volatile commodity chemicals sector.
Looking ahead, the company is expected to face continued financial pressure, with a negative operating income and declining profitability. The capital expenditures suggest a commitment to maintaining or expanding operations, but the negative free cash flow indicates that the company is not generating sufficient cash to fund these investments internally. The outlook for the next fiscal year remains uncertain, with no clear signs of improvement in the current financial trajectory.
The company's risk profile is marked by medium liquidity risk and low dilution potential. The negative net cash position after subtracting total debt is a key flag, indicating potential challenges in meeting short-term obligations. The company has not disclosed any recent dilutive events, and the dilution potential remains low, suggesting that the ownership structure is relatively stable.
There are no recent events or filings disclosed in the available data that would indicate significant changes in the company's operations or financial strategy. The absence of recent transcripts or filings suggests a lack of public communication about strategic initiatives or financial performance.
CGN Nuclear Technology Development Co Ltd (000881.SZ) has undergone a significant reclassification in its business taxonomy, with its primary activity now identified as "Chemicals" and its economic sector designated as "Basic Materials." This shift represents a medium-severity change in the company's profile, moving from an undefined classification to a specific industrial categorization that aligns with the chemical and materials manufacturing space. Concurrently, the company's risk assessment framework has been updated with new baseline metrics. Dilution risk is now classified as "low," indicating a stable capital structure with minimal threat of share value erosion from new issuances. This assessment provides a clearer picture of shareholder equity protection, a key factor for long-term investors monitoring capital allocation strategies. In contrast, liquidity risk has been established at a "medium" level. This classification suggests that while the company maintains operational fluidity, there are moderate considerations regarding the ease of trading its shares or accessing immediate capital without significant price impact. This metric is crucial for understanding the stock's trading dynamics and potential volatility under market stress. These updates collectively refine the investment thesis for CGN Nuclear Technology Development, offering a more granular view of its sector positioning and risk profile. With no current analyst coverage or index membership data available, these newly defined risk and taxonomy parameters serve as foundational indicators for evaluating the company's standing within the Basic Materials sector.
- The company is operating at a loss, with a negative net income and operating income.
- The company's capital structure is moderately leveraged, with a debt-to-equity ratio of 0.62.
- Profitability is weak, with a return on equity of -6.92% and a return on assets of -3.38%.
- The company is investing heavily in capital expenditures, but is not generating sufficient free cash flow to support these investments.
- The company's liquidity position is medium risk, with a current ratio of 1.91 but negative net cash after debt.
- The company's business is concentrated in a single segment, with no geographic diversification disclosed.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- CGN Nuclear Technology Development Co Ltd Market data — financials · 2026-05-26
Ownership & reference
Insider activity
Short positioning
Geographic breakdown
Intel & risk
4 tracked-field change(s) detected vs prior analysis; max severity: medium.
- Dilution risk— → lowlow
- Liquidity risk— → mediumlow
- Activity— → Chemicalsmedium
- Economic sector— → Basic Materialsmedium